The effect of rosiglitazone on serum lipoprotein(a) levels in Korean patients with type 2 diabetes mellitus.

Ko, Seung Hyun; Song, Ki-Ho; Ahn, Yu-Bae; Yoo, Soon-Jib; Son, Hyun-Shik; Yoon, Kun-Ho; Cha, Bong-Yun; Lee, Kwang-Woo; Son, Ho-Young; Kang, Sung-Koo

Ko, Seung Hyun; Song, Ki-Ho; Ahn, Yu-Bae; Yoo, Soon-Jib; Son, Hyun-Shik; Yoon, Kun-Ho; Cha, Bong-Yun; Lee, Kwang-Woo; Son, Ho-Young; Kang, Sung-Koo.

Affiliation

Ko SH; Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea, South Korea.

Metabolism ; 52(6): 731-4, 2003 Jun.

Article in En | MEDLINE | ID: mdl-12800099

Subject(s)

Asian People; Diabetes Mellitus, Type 2/blood; Diabetes Mellitus, Type 2/drug therapy; Hypoglycemic Agents/therapeutic use; Lipoprotein(a)/blood; Thiazoles/therapeutic use; Thiazolidinediones; Aged; Blood Glucose/analysis; Diabetes Mellitus, Type 2/ethnology; Female; Glycated Hemoglobin/analysis; Humans; Korea; Lipids/blood; Male; Middle Aged; Rosiglitazone

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Lipoprotein(a) / Thiazolidinediones / Asian People / Diabetes Mellitus, Type 2 / Hypoglycemic Agents Type of study: Clinical_trials / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Metabolism Year: 2003 Type: Article Affiliation country: South Korea

Search on Google

XML

PubMed Links